EUTM file information

008462822

NORVIPREN


July 30, 2009

Trademark Summary

The trademark NORVIPREN was filed by SANDOZ AG, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on September 13, 2009, and received one opposition filed on December 9, 2009 by Abbott Laboratories on Likelihood of confusion. the opponent was represented by Zimmermann, Susanne and proceedings were handled in German, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued December 9, 2009

The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).

The renewal of the trademark was recorded by the office on June 4, 2019.

Change of name and address of the trademark registration was recorded on November 7, 2009. Appointment and Replacement of representative of the trademark registration was recorded on June 9, 2011. Licences granted of the trademark registration was recorded on November 6, 2011. Change of name and professional address of the trademark registration was recorded on April 4, 2016. Appointment and Replacement of representative of the trademark registration was recorded on May 25, 2016. Change of name and address of the trademark registration was recorded on January 19, 2017. Change of name and address of the trademark registration was recorded on January 25, 2017. Change of name and address of the trademark registration was recorded on January 29, 2017. Change of name and address of the trademark registration was recorded on February 27, 2017. Change of name and professional address of the trademark registration was recorded on August 25, 2020. A transfer of the trademark registration was recorded on October 8, 2023. Change of name and address of the trademark registration was recorded on July 2, 2024.


Goods And Services

  • The mark was filed in class 5 with Pharmaceutical preparations, namely analgesic / antirheumatic drugs.